Exelixis’ Cabometyx R&D On Track Despite Pivotal Kidney Cancer Setback

 
• By Ayisha Sharma
  
Blue and purple graphic image of pair of kidneys
There Could Be 15,000 Deaths Due To Kidney Cancer This Year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D